EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations

Francesca Galvani iD, Daniele Pala, Alberto Cuzzolin, Laura Scalvini iD, Alessio Lodola iD, Marco Mor iD, Andrea Rizzi

Journal of Chemical Information and Modeling · 2023

DOI: 10.1021/acs.jcim.3c00042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, 2023. Verfasst von Francesca Galvani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Scienze degli Alimenti e del Farmaco, Università degli Studi di Parma, Parco Area delle Scienze 27/A, I-43124 Parma, Italy. Hauptthemen laut MEDLINE: Receptor, Muscarinic M3, Molecular Dynamics Simulation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Regione Emilia-Romagna.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The residence time (RT), the time for which a drug remains bound to its biological target, is a critical parameter for drug design. The prediction of this key kinetic property has been proven to be challenging and computationally demanding in the framework of atomistic simulations. In the present work, we setup and applied two distinct metadynamics protocols to estimate the RTs of muscarinic M3 receptor antagonists. In the first method, derived from the conformational flooding approach, the kinetics of unbinding is retrieved from a physics-based parameter known as the acceleration factor α (i.e., the running average over time of the potential deposited in the bound state). Such an approach is expected to recover the absolute RT value for a compound of interest. In the second method, known as the tMETA-D approach, a qualitative estimation of the RT is given by the time of simulation required to drive the ligand from the binding site to the solvent bulk. This approach has been developed to reproduce the change of experimental RTs for compounds targeting the same target. Our analysis shows that both computational protocols are able to rank compounds in agreement with their experimental RTs. Quantitative structure-kinetics relationship (SKR) models can be identified and employed to predict the impact of a chemical modification on the experimental RT once a calibration study has been performed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Muscarinic M3Molecular Dynamics SimulationKineticsLigandsPhysics

Substanzen

Receptor, Muscarinic M3Ligands

Autor:innen und Institutionen

  • Dipartimento di Scienze degli Alimenti e del Farmaco, Università degli Studi di Parma, Parco Area delle Scienze 27/A, I-43124 Parma, Italy.
  • Chemistry Research and Drug Design Department, Chiesi Farmaceutici S.p.A., Largo F. Belloli 11/A, 43122 Parma, Italy.
  • Microbiome Research Hub, University of Parma, Parco Area delle Scienze 11/A, I-43124 Parma, Italy.

ORCID-Profile: Francesca Galvani, Laura Scalvini, Alessio Lodola, Marco Mor

Förderung

  • Regione Emilia-Romagna

Zitieren

APA

Galvani, F., Pala, D., Cuzzolin, A., Scalvini, L., Lodola, A., Mor, M., & Rizzi, A. (2023). Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations. Journal of Chemical Information and Modeling. https://doi.org/10.1021/acs.jcim.3c00042

Vancouver

Galvani F, Pala D, Cuzzolin A, Scalvini L, Lodola A, Mor M, et al. Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations. Journal of Chemical Information and Modeling. 2023. doi:10.1021/acs.jcim.3c00042

BibTeX
@article{Galvani2023,
  author = {Galvani, Francesca and Pala, Daniele and Cuzzolin, Alberto and Scalvini, Laura and Lodola, Alessio and Mor, Marco and Rizzi, Andrea},
  title = {Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations},
  journal = {Journal of Chemical Information and Modeling},
  year = {2023},
  doi = {10.1021/acs.jcim.3c00042}
}
Kostenlos starten →